Fleury S.A. (BVMF:FLRY3)

Brazil flag Brazil · Delayed Price · Currency is BRL
12.29
-0.07 (-0.57%)
Apr 17, 2025, 5:07 PM GMT-3
-5.24%
Market Cap 6.69B
Revenue (ttm) 7.68B
Net Income (ttm) 616.17M
Shares Out 544.28M
EPS (ttm) 1.13
PE Ratio 10.87
Forward PE 9.89
Dividend 1.02 (8.28%)
Ex-Dividend Date Mar 7, 2025
Volume 3,050,100
Average Volume 3,020,140
Open 12.37
Previous Close 12.36
Day's Range 12.11 - 12.41
52-Week Range 10.65 - 16.87
Beta 0.38
RSI 63.23
Earnings Date May 8, 2025

About Fleury

Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and imaging tests, genomics, health management and platform, diagnostic information, check-up and reference laboratory, clinic day, infusion center, orthopedics and ophthalmology, dental imaging tests, and diagnostic imaging se... [Read more]

Sector Healthcare
Founded 1926
Employees 27,500
Stock Exchange Brazil Stock Exchange
Ticker Symbol FLRY3
Full Company Profile

Financial Performance

In 2024, Fleury's revenue was 7.68 billion, an increase of 18.76% compared to the previous year's 6.47 billion. Earnings were 616.17 million, an increase of 45.41%.

Financial Statements

News

Fleury SA (BSP:FLRY3) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market ...

Fleury SA (BSP:FLRY3) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges

5 months ago - GuruFocus

Q3 2024 Fleury SA Earnings Call (English, Portuguese) Transcript

Q3 2024 Fleury SA Earnings Call (English, Portuguese) Transcript

5 months ago - GuruFocus